Back

Renilon 4.0

Features
  • 250kcal/bottle (2kcal/ml): energy-dense ONS^ for patients requiring fluid or volume restriction.
  • 5g protein/bottle (8% energy): decreased protein level to prevent an overloading of nitrogenous waste products due to impaired excretion.1,2
  • Reduced mineral content (sodium, potassium, chloride, calcium, phosphorus, magnesium): for patients that require select mineral restriction.
  • Enriched with several micronutrients for their antioxidant properties (zinc, copper, manganese, selenium, carotenoids, vitamin E, riboflavin, vitamin B6, folic acid, vitamin B12) : to support and mitigate increased oxidative stress in pre-dialysis patients.3-12
  • Does not contain preformed vitamin A: to reduce the risk of hypervitaminosis.11,13-17
  • No added fibre: for patients requiring residue-restricted diets.
  • Small volume (125ml): for patients requiring fluid on volume restriction.
  • User-friendly bottle: ergonomic plastic bottle, with resealable easy to open cap.

Product Information

A ready-to-drink, high energy, low protein, reduced mineral oral nutritional supplement for the dietary management of patients with renal disease (pre-dialysis).

Link copied!
Indications

For the dietary management of:

  • Disease-related malnutrition.
  • Patients with renal disease receiving conservative treatment (pre-dialysis).
  • Patients requiring a fluid or volume restriction.
  • Patients requiring a select mineral restriction.
Important Notice
  • Not suitable as a sole source of nutrition.
  • Not suitable for parenteral use.
  • Not suitable for patients with galactosaemia.
  • Not suitable for patients with cow’s milk protein allergy.
  • Not suitable for infants and children under 3 years of age.
  • Must be used under medical supervision.
Directions of Use
  • Shake well before use.
  • Best served chilled.
  • Usage to be determined by a healthcare professional.
Storage
  • Store in a cool, dry place.
  • Once opened, close the bottle and store in the refrigerator.
  • Discard unused contents after 24 hours.
Order Information

To order contact Nutricia Customer Experience 1800 889 480

Renilon 4.0 Presentation Code Units per carton
Apricot 125ml bottle 70977 24
Ingredients

Full ingredients list and nutritional information is available on the product fact sheet.

Allergen & Cultural Information
  • Contains: milk and soy.
  • Halal certified.
  • No gluten containing ingredients. No detectable gluten when tested to a sensitivity level of less than 5 parts per million (<5 ppm i.e. <5mg/kg).
  • Low lactose (lactose <2g/100g).
References
  1. Toigo G, Aparicio M, Attman PO et al. Consensus Report. Expert working group report on nutrition in adult patients with renal insufficiency (part 1 of 2). Clin Nutr 2000; 19: 197-207.
  2. Toigo G, Aparicio M, Attman PO et al. Consensus Report. Expert working group report on nutrition in adult patients with renal insufficiency (part 2 of 2). Clin Nutr 2000; 19: 281-291.
  3. Chugh SN, Jain S, Agrawal N, Sharma A. Evaluation of oxidative stress before and after haemodialysis in chronic renal failure. J Assoc Physicians India 2000; 48: 981-84.
  4. Ceballos-Picot I, Witko-Sarsat V, Merad-Boudia M, Nguyen AT et al. Glutathione antioxidant system as a marker of oxidative stress in chronic renal failure. Free Radic Biol Med 1996; 21: 845-53.
  5. Martin-Mateo MC, Sanchez-Portugal M, Iglesias S, de Paula A, Bustamante J. Oxidative stress in chronic renal failure. Ren Fail 1999; 21: 155-67.
  6. Mimic-Oka J, Simic T, Djukanovic L, Reljic Z, Davicevic Z. Alteration in plasma antioxidant capacity in various degrees of chronic renal failure. Clin Nephrol 1999; 51: 233-41.
  7. Richard MJ, Arnaud J, Jurkovitz C, Hachache T et al. Trace elements and lipid peroxidation abnormalities in patients with chronic renal failure. Nephron 1991; 57: 10-5.
  8. Stratton R. Rationale for the addition of carotenoids to enteral tube and sip feeds. Nutricia Healthcare 2000, on file.
  9. Islam KN, O’Byrne D, Devaraj S, Palmer B et al. Alpha-tocopherol supplementation decreases the oxidative susceptibility of LDL in renal failure patients on dialysis therapy. Atherosclerosis 2000; 150: 217-24.
  10. Makoff R, Dwyer J, Rocco MV. Folic acid, pyridoxine, cobalamin and homocysteine and their relationship to cardiovascular disease in end-stage renal disease. J Renal Nutr 1996; 6: 2-11.
  11. Makoff R. Vitamin replacement therapy in renal failure patients. Miner Electrolyte Metab 1999; 25: 349-351.
  12. Bender DA, Bender AE. Nutrition. A reference handbook. Oxford: Oxford University Press, 1997.
  13. Muth I. Implications of hypervitminosis A in chronic renal failure. J Renal Nutr 1991; 1: 2-8.
  14. Khan IH, Richmond P, Macleod AM. Diseases of the kidneys and urinary tract. In: Garrow JS, James WPT, Ralph A (eds). Human nutrition and dietetics. Tenth edition. Edinburgh; Churchill Livingstone; 2000; 667-687.
  15. Goldstein DJ, Abrahamian-Gebeshian C. Nutrition support in renal failure. In: Matarese LE, Gottschlich MM (eds). Contemporary Nutrition Support Practice. A Clinical Guide. Philadelphia: WB Saunders 1998; 447-47.
  16. Ha TK, Sattar N, Talwar D, Cooney J, Simpson K, O’Reilly DS et al. Abnormal antioxidant vitamin and carotenoid status in chronic renal failure. QJM 1996; 89: 765-769.
  17. Allman MA, Truswell AS, Tiller DJ, Stewart PM et al. Vitamin supplementation of patients receiving haemodialysis. Med J Aust 1989; 150: 130-133.
Additional Information

Food for special medical purposes for use under medical supervision.